
Discover Viatris
Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis

Discover Viatris
Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia

Discover Viatris
Viatris Named to TIME’s World’s Most Sustainable Companies 2025 List

Discover Viatris